Jami Nachtsheim - Aug 27, 2021 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role: Director
Signature: /s/ Jennifer McNealey, as Attorney-in-Fact
Stock symbol: TBIO
Transactions as of: Aug 27, 2021
Transactions value $: $0
Form type: 4
Date filed: 9/7/2021, 09:26 PM
Previous filing: Jun 17, 2021
Next filing: Mar 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Stock Option (right to buy)	Award	$0	+117K		$0.00	117K	Aug 27, 2021	Common Stock	117K	$11.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's. 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining Shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 1, 2021.

Content

Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's. 2021 Equity Incentive Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining Shares subject to the option shall vest in equal monthly installments on the same day of the month as the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 1, 2021.